The relationship between the neutrophil-lymphocyte ratio and the coronary collateral circulation in patients with

Me Kalkan1, M Sahin1, Ak Kalkan2

  • 1Department of Cardiology, Kartal Kosuyolu High Specialty Education and Research Hospital, Istanbul, Turkey.

Perfusion
|February 19, 2014
PubMed

Insights

The neutrophil-lymphocyte ratio (NLR) is higher in patients with poor coronary collateral circulation (CCC) in chronic total occlusion (CTO). This simple inflammatory marker can help predict CCC development in these patients.

Area of Science:

  • Cardiology
  • Inflammation Markers
  • Vascular Biology

Background:

  • Previous studies link higher neutrophil and lower lymphocyte counts to adverse cardiovascular outcomes.
  • Coronary collateral circulation (CCC) plays a crucial role in mitigating ischemia in coronary chronic total occlusion (CTO).

Purpose of the Study:

  • To investigate the association between the neutrophil-lymphocyte ratio (NLR) and the development of CCC in patients with CTO.
  • To determine if NLR can serve as a predictor of poor CCC development.

Main Methods:

  • A study included 274 patients diagnosed with CTO.
  • Patients were categorized into groups with poor (Rentrop grades 0-1) or good (Rentrop grades 2-3) CCC.
  • Clinical data and blood analyses were retrospectively collected.

Main Results:

  • Patients with poorly developed CCC exhibited significantly higher NLR values compared to those with good CCC (2.6 ± 0.5 vs 2.2 ± 0.4, p<0.001).
  • Univariate analysis identified NLR, hs-CRP, WBC, age, diabetes, fasting glucose, and BMI as associated with poor CCC.
  • Multivariate analysis revealed NLR (OR 1.88, 95% CI 1.37-2.74; p<0.001), hs-CRP, and WBC as independent predictors of poor CCC.
  • Optimal NLR cut-off for predicting poor CCC was 2.17 (77% sensitivity, 65% specificity).

Conclusions:

  • NLR is a significant, simple, and inexpensive marker for estimating CCC development in CTO patients.
  • NLR can be utilized by cardiologists as a screening tool for inflammation.
  • This finding highlights NLR's potential as a novel cardiovascular risk marker.
Abstract